BrainStorm Cell Therapeutics Data Show Treatment with NurOwn Significantly Reduces NfL, a Key Biomarker of Neurodegeneration

New data released by BrainStorm Cell Therapeutics has revealed promising results for their ALS treatment, NurOwn. The Phase 3 trial showcased a significant reduction in the neurodegeneration biomarker, NfL, among participants who received NurOwn compared to those who were given a placebo. The decision to analyze biomarker data was influenced by recent FDA approvals for ALS drugs and the correlat..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 10.
  • textsms

Korea University Medicine Study Identifies a New Biomarker for Major Depressive Disorder

Korea University Medicine Study Highlights a New Biomarker for Major Depressive Disorder The human brain, specifically its outermost cortex, is riddled with folds or 'gyri' essential for its proper functioning. Unsurprisingly, therefore, abnormal gyrification i.e., the development of gyri, can manifest as serious neurological disorders, including the highly disabling and widespread mental illnes..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 6.
  • textsms